BioengineeringNature Cardiovascular ResearchPeer-reviewed
A Drug-Elicitable Alternative-Splicing Module (DreAM) for Tunable AAV Expression and Controlled Myocardial Regeneration
17 citationstop 2%
Author
Peking UniversityORCID 0000-0002-2625-0935Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Baochen Bai, Jiting Li, Ze Wang…·Yuxuan Guo
This study shows neural organoids protect engineered heart tissues from glucolipotoxicity by transferring versican, identified through co-culture experiments and functional assays.
Zhanzhao Liu, Luzi Yang, Yuhan Yang…·Yuxuan Guo
This study shows that single-AAV delivery of base editors can achieve effective cardiac gene silencing with higher success rates than dual-AAV systems.